CEA (TF 3H8-1) Primary Antibody

Skip to Content

Skip over Generic Navigation

  • Select your country:
DIAGNOSTICS F. Hoffmann-La Roche Ltd

Anti-CEA (TF 3H8-1) Primary Antibody

Anti-CEA (TF 3H8-1) Primary Antibody, colon, 200x
Catalog Number:760-2507
Ordering Code:05266947001
Quantity:50 tests
Clone Name:TF3H8-1
Regulatory Status:IVD

This antibody is intended for in vitro diagnostic use. Ventana Medical Systems. Inc. (Ventana) CEA (TF 3H8-1) Primary Antibody may be used to aid in the identification of cells of normal and abnormal epithelial lineage as an aid in diagnosis of anaplastic tumors. CEA (TF 3H8-1) Primary Antibody specifically binds to antigens located in the plasma membrane and cytoplasmic regions of normal simple epithelial cells. CEA (TF 3H8-1) is a mouse monoclonal antibody (IgG1) directed against carcinoembryonic antigen (CEA). The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Health Care Provider Notice
This website is intended for healthcare professionals only.

The content on this website is intended for healthcare professionals only. Information intended for the general public can be found on Roche.com. Please confirm that you are a medical professional before accessing the content of this website.

Yes, I hereby certify that I am a healthcare professional. Continue
Third-Party Link Disclosure
Disclosure for Links to Third-Party Websites

You are now leaving the Roche website. The site you are about to visit is operated by third-parties. The link to this site neither makes nor implies any representation or warranty for any products or services offered on a third-party site and is intended only to enable convenient access to the third-party site and for no other purpose.